Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
This study has been completed.
Information provided by:
First received: October 20, 2006
Last updated: August 17, 2010
Last verified: August 2010
Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Theravance, Inc.:
Contacts and Locations